{"altmetric_id":2592761,"counts":{"readers":{"mendeley":4,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["dermatologyf"],"posts_count":1}},"citation":{"abstract":"Oral propranolol has become the treatment of choice of infantile hemangiomas (IH)s. However, the safety of systemic propranolol is questioned. Topical therapy with 1% propranolol has been reported to be safe and effective. Intralesional (IL) administration may possibly allow safe delivery of higher drug dosages.","abstract_source":"pubmed","altmetric_jid":"4f6fa6173cf058f610007344","authors":["Zaher H","Rasheed H","Esmat S","Hegazy RA","Gawdat HI","El-Komy M","Abdelhalim DM"],"doi":"10.1684\/ejd.2013.2146","first_seen_on":"2014-08-13T10:01:23+00:00","issns":["1167-1122"],"issue":"","journal":"European Journal of Dermatology","last_mentioned_on":1407924040,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24135427?dopt=Abstract"],"pmid":"24135427","pubdate":"2013-10-20T00:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["dermatology"],"title":"Propranolol and infantile hemangiomas: Different routes of administration, a randomized clinical trial.","type":"article","volume":"","mendeley_url":"http:\/\/www.mendeley.com\/research\/propranolol-infantile-hemangiomas-different-routes-administration-randomized-clinical-trial-5"},"altmetric_score":{"score":1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":4507652,"mean":5.1453542744813,"rank":2295727,"this_scored_higher_than_pct":35,"this_scored_higher_than":1618083,"rank_type":"exact","sample_size":4507652,"percentile":35},"similar_age_3m":{"total_number_of_other_articles":111066,"mean":8.0660843470042,"rank":54534,"this_scored_higher_than_pct":38,"this_scored_higher_than":42247,"rank_type":"exact","sample_size":111066,"percentile":38},"this_journal":{"total_number_of_other_articles":243,"mean":1.6682727272727,"rank":96,"this_scored_higher_than_pct":46,"this_scored_higher_than":114,"rank_type":"exact","sample_size":243,"percentile":46},"similar_age_this_journal_3m":{"total_number_of_other_articles":10,"mean":0.63333333333333,"rank":2,"this_scored_higher_than_pct":70,"this_scored_higher_than":7,"rank_type":"exact","sample_size":10,"percentile":70}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Unspecified":1,"Student  > Master":1,"Student  > Bachelor":2},"by_discipline":{"Medicine and Dentistry":3,"Unspecified":1}}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/dermatologyf\/status\/499495745699844096","license":"datasift","citation_ids":[2592761],"posted_on":"2014-08-13T10:00:40+00:00","author":{"name":"dermatologyf","image":"https:\/\/pbs.twimg.com\/profile_images\/2046835740\/favicon_normal.ico","description":"Dermatology News","id_on_source":"dermatologyf","tweeter_id":"546505902","geo":{"lt":null,"ln":null},"followers":58},"tweet_id":"499495745699844096"}]}}